Sigurður Ólafsson

Emailsigurdollandspitaliis

Research activity per year

Fingerprint

Dive into the research topics where Sigurður Ólafsson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

45 Article
2 Conference contribution
2 Editorial
1 Letter
More
- 1 Short survey
- 1 Review article

Marked Reduction in HIV/HCV Coinfections in Iceland Following the TraP HepC Nationwide Hepatitis C Elimination Program
Hlynsdottir, K., Olafsson, S., Hernandez, U. B., Kristjansson, M. & Gottfredsson, M., 1 Jan 2026, In: Open Forum Infectious Diseases. 13, 1, p. ofaf806 ofaf806.
University of Iceland, Landspitali
Research output: Contribution to journal › Article › peer-review

Open Access
Clinically Important Decrease in Liver Stiffness Following Treatment for Hepatitis C: Outcome of the TraP HepC Nationwide Elimination Program
Kristjánsson, S. F., Olafsson, S., Gottfredsson, M., Love, T. J. & Björnsson, E. S., 5 Jun 2025, In: Journal of Clinical Medicine. 14, 11, 3982.
University of Iceland, Landspitali
Research output: Contribution to journal › Article › peer-review

Open Access
Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies
Razavi, H. A., Waked, I., Qureshi, H., Kondili, L. A., Duberg, A.-S., Aleman, S., Tanaka, J., Lazarus, J. V., Low-Beer, D., Abbas, Z., Rached, A. A., Aghemo, A., Aho, I., Akarca, U. S., Al-Busafi, S. A., Al-Hamoudi, W. K., Al-Naamani, K., Alaama, A. S., Aldar, M. M. & Alghamdi, M. & 135 others, Gonzalez, M. A., Alserehi, H., Anand, A. C., Asselah, T., Assiri, A. M., Athanasakis, K., Atugonza, R., Ben-Ari, Z., Berg, T., Brandão-Mello, C. E., Brown, A. S. M., Brown, K. A., Brown, R. S., Bruggmann, P., Brunetto, M. R., Buti, M., Cheinquer, H., Christensen, P. B., Chulanov, V., Cisneros Garza, L. E., Coffin, C. S., Coppola, N., Craxi, A., Crespo, J., Cui, F., Dalgard, O., De La Torre, A., De Ledinghen, V., Dieterich, D., Drazilova, S., Dufour, J.-F., El-Kassas, M., Elbadri, M., Esmat, G., Mur, R. E., Eurich, B., Faini, D., Ferreira, P. R. A., Flisiak, R., Frankova, S., Gaeta, G. B., Gamkrelidze, I., Gane, E. J., Garcia, V., García-Samaniego, J., Gemilyan, M., Gottfreðsson, M., Gschwantler, M., Gurski, A. P. M., Hajarizadeh, B., Hamid, S. S., Hatzakis, A., Hercun, J., Hockicková, I., Huang, J.-F., Hunyady, B., Hutchinson, S. J., Ishikawa, N., Izumi, K., Izzi, A., Janicko, M., Jarcuska, P., Jeruma, A., Johannessen, A., Kaliaskarova, K. S., Kao, J.-H., Kielland, K. B., Kodjoh, N., Kottilil, S., Kristian, P., Kwo, P. Y., Lagging, M., Lam, H., Lázaro, P., Lee, M.-H., Lens, S., Liakina, V., Lim, Y.-S., Makara, M., Manns, M., Manzengo, C. M., Memon, S., Mendes-Correa, M. C., Messina, V., Midgard, H., Murphy, N., Musabaev, E., Naveira, M. C. M., Nde, H., Negro, F., Nim, N., Ocama, P., Ólafsson, S., Omuemu, C. E., Pamplona, J. J., Pan, C. Q., Papatheodoridis, G. V., Pimenov, N., Poustchi, H., Quaranta, M. G., Ramji, A., Rautiainen, H., Razavi-Shearer, D. M., Razavi-Shearer, K., Ridruejo, E., Ríos-Hincapié, C. Y., Sadirova, S., Sanai, F. M., Sarrazin, C., Sarybayeva, G., Schréter, I., Seguin-Devaux, C., Sereno, L. S., Shiha, G., Smith, J., Soliman, R., Sonderup, M. W., Spearman, C. W., Stauber, R. E., Stedman, C. A. M., Sypsa, V., Tacke, F., Terrault, N. A., Tolmane, I., Van Welzen, B., Voeller, A. S., Waheed, Y., Wallace, C., Whittaker, R. N., W-S Wong, V., Ydreborg, M., Yesmembetov, K., Yu, M.-L., Zeuzem, S. & Zuckerman, E., Aug 2025, In: Journal of Hepatology. 83, 2, p. 329-347 19 p.
University of Iceland, Landspitali
Research output: Contribution to journal › Article › peer-review

Open Access
Incidence of cirrhosis in Iceland—impact of the TraP HepC nationwide HCV elimination program
Haraldsson, H. A., Ólafsson, S., Gottfreðsson, M., Hernandez, U. B. & Björnsson, E. S., Jul 2024, In: Scandinavian Journal of Gastroenterology. 59, 7, p. 835-842 8 p.
Landspitali, University of Iceland
Research output: Contribution to journal › Article › peer-review

Open Access
Predictors of treatment outcomes for Hepatitis C infection in a nationwide elimination program in Iceland: The treatment as prevention for Hepatitis C (TraP HepC) study
the TraP Hep C working group, Ólafsson, S., Löve, Þ. J., Bergmann, Ó. M., Björnsson, E. S., Jóhannsson, B., Sigurðardóttir, B., Löve, A., Baldvinsdóttir, G. E., Hernandez, U. B. & Gottfreðsson, M., Nov 2024, In: International Journal of Drug Policy. 133, 104616.
University of Iceland, Landspitali
Research output: Contribution to journal › Article › peer-review

Open Access

Sigurður Ólafsson

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

Marked Reduction in HIV/HCV Coinfections in Iceland Following the TraP HepC Nationwide Hepatitis C Elimination Program

Clinically Important Decrease in Liver Stiffness Following Treatment for Hepatitis C: Outcome of the TraP HepC Nationwide Elimination Program

Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies

Incidence of cirrhosis in Iceland—impact of the TraP HepC nationwide HCV elimination program

Predictors of treatment outcomes for Hepatitis C infection in a nationwide elimination program in Iceland: The treatment as prevention for Hepatitis C (TraP HepC) study

Sigurður Ólafsson

Fingerprint

Collaborations and top research areas from the last five years

Research output

Marked Reduction in HIV/HCV Coinfections in Iceland Following the TraP HepC Nationwide Hepatitis C Elimination Program

Clinically Important Decrease in Liver Stiffness Following Treatment for Hepatitis C: Outcome of the TraP HepC Nationwide Elimination Program

Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies

Incidence of cirrhosis in Iceland—impact of the TraP HepC nationwide HCV elimination program

Predictors of treatment outcomes for Hepatitis C infection in a nationwide elimination program in Iceland: The treatment as prevention for Hepatitis C (TraP HepC) study